Kolexia
Bonello Laurent
Cardiologie
Hôpital Nord Marseille
Marseille, France
334 Activités
732 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndrome coronarien aigu Infarctus du myocarde Choc cardiogénique Choc Infarctus Hémorragie Maladie des artères coronaires Thrombose Défaillance cardiaque

Industries

Boston Scientific
5 collaboration(s)
Dernière en 2022
AstraZeneca
2 collaboration(s)
Dernière en 2023
Abiomed
1 collaboration(s)
Dernière en 2020
Novartis
1 collaboration(s)
Dernière en 2020

Dernières activités

Optimal Heart Failure Medical Therapy and Mortality in Survivors of Cardiogenic Shock: Insights From the FRENSHOCK Registry.
Journal of the American Heart Association   23 février 2024
Beta Blockers Improve Prognosis When Used Early in Patients with Cardiogenic Shock: An Analysis of the FRENSHOCK Multicenter Prospective Registry.
Pharmaceuticals (Basel, Switzerland)   18 décembre 2023
Very early invasive strategy in patients with non-ST-elevation myocardial infarction: should we go for it?
Heart (British Cardiac Society)   16 décembre 2023
Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion.
Frontiers in cardiovascular medicine   16 novembre 2023
Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry.
International journal of cardiology   11 novembre 2023
One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry
ESC Congress 2023 25–28 August 2023 Amsterdam, Netherlands Abstract Supplement   09 novembre 2023
Characteristics, management, and outcomes of active cancer patients with cardiogenic shock.
European heart journal. Acute cardiovascular care   27 octobre 2023
INNOV CKD 1: Evaluation of the Effectiveness of Platelet-based and Microvesicle-based Assays to Predict Thrombotic and Bleeding Risk in Chronic Kidney Disease Patients With Acute Coronary Syndrome
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   26 octobre 2023
AQUATIC: Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease
Essai Clinique (Bayer)   29 septembre 2023
Cardiogenic Shock in Idiopathic Dilated Cardiomyopathy Patients: Red Flag for Myocardial Decline.
The American journal of cardiology   08 septembre 2023